Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6699220 | 7368030 | I | 6699220-5 | 20070906 | 20100413 | 20100427 | EXP | GB-GENENTECH-300719 | GNEFDAAERSPRD | 79 | YR | M | Y | 20100427 | CN | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6699220 | 1013579874 | PS | RITUXIMAB | 2 | UNKNOWN | 800 MG, X4 | NOT REPORTED | ||||
| 6699220 | 1013579875 | C | CYCLOPHOSPHAMIDE | 1 | INTRAVENOUS | 750 MG, UNK | NOT REPORTED | ||||
| 6699220 | 1013579876 | C | METHYLPREDNISOLONE | 2 | INTRAVENOUS | 1 G, UNK | NOT REPORTED |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6699220 | 1013579874 | ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
| 6699220 | 1013579875 | ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
| 6699220 | 1013579876 | DRUG USE FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6699220 | DS |
Reactions reported
| Event ID | PT |
|---|---|
| 6699220 | CEREBROVASCULAR ACCIDENT |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6699220 | 1013579874 | 20070612 | 20070704 | 23 | DAY |
| 6699220 | 1013579875 | 20070605 | 20070619 | 15 | DAY |
| 6699220 | 1013579876 | 20070607 | 20070607 | 1 | DAY |